A new editor-in-chief, who is recognised as a global authority on corruption and transparency in the pharmaceutical industry, has been appointed to lead the Journal of Pharmaceutical Health Services Research (JPHSR).
Jillian Kohler, a professor at the University of Toronto’s Leslie Dan Faculty of Pharmacy, the Dalla Lana School of Public Health and the Munk School of Global Affairs and Public Policy, was appointed in January 2023 by the Royal Pharmaceutical Society (RPS).
Kohler is the founding director of the World Health Organization (WHO) Collaborating Centre for Governance, Transparency and Accountability in the Pharmaceutical Sector, which was established in 2015, and has worked on the methodology on good governance in the pharmaceutical system for the World Bank, which has been applied in over 38 countries globally.
Her research career has focused on global access to essential medicines, including issues such as anti-corruption, transparency and accountability in the pharmaceutical sector, trade issues and intellectual property rights.
Kohler is also a technical adviser for the Access to Medicines Index and was an adviser to the now-concluded WHO Good Governance for Medicines Programme. She has also provided technical advice to the WHO, World Bank, United Nations Development Programme and the Bill and Melinda Gates Foundation.
The JPHSR‘s previous editor-in-chief, Albert Wertheimer, professor of sociobehavioral and administrative pharmacy at Nova Southeastern University, stepped down in January 2023 after 14 years at the journal.
In a statement issued upon her new appointment, Kohler said: “As a political scientist, who has been actively engaged in the pharmaceutical health services research area for over 25 years, I hope to offer a perspective that can contribute to the rich multidisciplinary nature of the journal.”
Kohler added that she aims to increase inclusiveness and ensure an even greater diversity of perspectives are represented in the JPHSR.
The JPHSR is a quarterly, peer-reviewed, international journal, dedicated to all aspects of health services research related to pharmaceuticals. It is owned by the Royal Pharmaceutical Society and publishes research that identifies the most effective ways to organise, manage, finance and deliver high-quality care, reduce medical errors and better patient safety to improve the health outcomes of patients.